Global Prefilled Syringe Industry Market Report 2019 | Forecast Till 2026 | By Type, End-use, Geography, Player
Prefilled Syringes are basically ready-to-use pharmaceutical products. Prefilled syringes are disposable syringes that contain liquid or substance which is to be administered to a patient prefilled. These are primarily used to deliver accurate dose of drugs to a patient, and is particularly useful when an individual is suffering from long-term conditions where-in self-administration of medication becomes necessary. Growth of the global prefilled syringes market is driven by industry players focusing intensely on research and development of new, easy-to-use, and cost-effective prefilled syringes, coupled with increasing availability of complex biological compounds that can be injected directly into a patient's body.
The global Prefilled Syringe market is estimated to be USD 9,827 million in 2019 and is expected to reach USD 20,778 million by 2026, with a CAGR of 11.29% during the forecast period.
Get FREE Sample of Prefilled Syringe Market Report at:
Key Dynamics
Ease of administration and reduced risk of contamination offered by these devices over the conventional delivery systems such as vial and ampoules are the key trends that are responsible for the wide adoption of prefilled syringes globally. Increasing prevalence of chronic disease such as diabetes, rheumatoid arthritis, cancer, etc. the diagnosis of which demand frequent drug injection is the major factor driving the global prefilled syringe market. Furthermore, increasing adoption of self-injection devices such as pen injectors, technological advancements in the drug delivery platforms and superior effectiveness of the prefilled syringes to reduce medication errors are the other major factors driving the demand for prefilled syringes. However, product recalls and stringent regulations are the major factors that impede the growth of global prefilled syringe market.
Segmentation
On the basis of type, Prefilled Syringe Market segmented into
l Glass
l Plastic
Based on the type, the market can be divided into Glass and Plastic. Glass prefilled syringes held a major share in 2016. However, the demand for plastic based prefilled syringes are increasing due to increasing awareness among healthcare practitioners and physicians to reduce medication errors as it offers clarity which is helpful to reduce medication errors.
On the application, Prefilled Syringe Market segmented into
l Autoimmune diseases
l Antithrombotics
l Vaccines
l Other
Purchase a copy of Prefilled Syringe report at:
Competitive Landscape
The prefilled syringe industry is mature and highly concentrated. Although there are more than 30 manufacturers in the world, while leading international giants such as BD, Gerresheimer, Nipro Corporation, Schott forma vitrum and Ompi, production is almost dominated by several manufacturers, especially BD, which accounts for more than 60% of global production. On the other hand, almost all the high-end products produced by the global leaders, and the producers mainly produce low-end products in China and India.
The United States and Europe have a long history and unshakable status in this industry, such as BD, which leads the prefilled syringe industry. As to Japan, the Nipro Corporation has become a global leader through acquisition MGlas AG. In Germany, it is Gerresheimer and Schott forma vitrum that lead the industry. In China, it is Shandong Gaowei Group Medical Polymer Company that leads the industry.
Major manufacturers profiled in the analysis report include BD(US), Gerresheimer(DE), Gerresheimer(DE), Nipro Corporation(JP), Schott forma vitrum(DE), Ompi(IT), Baxter BioPharma Solution(US), ROVI CM(ES), Terumo(JP), Vetter(DE), Unilife Corporation(US), Taisei Kako(JP), Roselabs Group(IN), ARTE CORPORATION(JP), Weigao Group Medical Polymer(CN), Zibo Minkang Pharmaceutical(CN), Shandong Pharmaceutical Glass(CN), and etc.
Regional Spotlights
North America and Europe have occupied a major share in the global prefilled syringe market, followed by the Asia Pacific, with the market share of 35.73%, 30.51%, and 27.47% respectively. The major reason for the dominance of Europe and North America is the constant increase in geriatric population, demand for quality healthcare, increasing trend of home-based treatment coupled with high healthcare expenditure in these regions that have facilitated the wide adoption of prefilled syringes. Asia-Pacific is projected to emerge as the fastest growing region in terms of market share. The growth of the Asia-Pacific region is witnessed owing to the increasing number of hospitals, clinics in Indian and China. Also, improving healthcare infrastructure is also predicted to supplement the growth of Asia-Pacific within the forecast period.
Overall Regions Outlook
l North America (U.S., Canada, Mexico)
l Europe (Germany, France, Italy, Spain, U.K., Nordic Countries, Belgium, Russia, Rest of Europe
l Asia Pacific (China, India, Australia, Japan, South Korea, Australia and New Zealand, Rest of Asia Pacific)
l Latin America, Middle East & Africa (Brazil, Nigeria, Argentina, South Africa, GCC Countries.
l Others
Table of Content
1 Report Overview
1.1 Product Definition and Scope
1.2 PEST (Political, Economic, Social and Technological) Analysis of Prefilled Syringe Market
…
2 Market Trends and Competitive Landscape
3 Segmentation of Prefilled Syringe Market by Types
4 Segmentation of Prefilled Syringe Market by End-Users
5 Market Analysis by Major Regions
6 Product Commodity of Prefilled Syringe Market in Major Countries
7 North America Prefilled Syringe Landscape Analysis
8 Europe Prefilled Syringe Landscape Analysis
9 Asia Pacific Prefilled Syringe Landscape Analysis
10 Latin America, Middle East & Africa Prefilled Syringe Landscape Analysis
11 Major Players Profile
11.1 BD(US)
11.1.1 BD(US) Company Profile and Recent Development
11.1.2 Market Performance
11.1.3 Product and Service Introduction
11.2 Gerresheimer(DE)
11.3 Nipro Corporation(JP)
11.4 Schott forma vitrum(DE)
11.5 Ompi(IT)
11.6 Baxter BioPharma Solution(US)
11.7 ROVI CM(ES)
11.8 Terumo(JP)
11.9 Vetter(DE)
11.10 Unilife Corporation(US)
11.11 Taisei Kako(JP)
11.12 Roselabs Group(IN)
11.13 ARTE CORPORATION(JP)
11.14 Weigao Group Medical Polymer(CN)
11.15 Zibo Minkang Pharmaceutical(CN)
11.16 Shandong Pharmaceutical Glass(CN)
…
In-depth Prefilled Syringe Market Report: Intended Audience
l Prefilled Syringe manufacturers
l Traders, distributors, and resellers of Prefilled Syringe
l Prefilled Syringe industry associations and research organizations
l Product managers, Prefilled Syringe industry administrator, C-level executives of the industries
l Healthcare organizations
l Market Research and consulting firms
Ask for a discount at:
Years considered for the study
l Base Year: 2018
l Estimated Year: 2019
l Forecast Period: 2019 to 2026
Contact Us
Global Market Monitor
One Pierrepont Plaza, 300 Cadman Plaza W, Brooklyn,
NY 11201, USA
Name: Rebecca Hall
Phone: + 1 (347) 467 7721
Email: info@globalmarketmonitor.com
Web Site: https://www.globalmarketmonitor.com
We provide more professional and intelligent market reports to complement your business decisions.
Chinese